RT Journal
A1 Hassaballa H
T1 ANemia in older patients
JF JAMA
JO JAMA
YR 1999
FD December 1
VO 282
IS 21
SP 2001
OP 2001
DO 10-1001/pubs.JAMA-ISSN-0098-7484-282-21-jbk1201
UL http://dx.doi.org/10-1001/pubs.JAMA-ISSN-0098-7484-282-21-jbk1201
AB 
First, all the statistically significant mortality data presented are
for the 0- to 5-year follow-up period. For the remaining 5- to 10-year follow-up
period, however, there is no difference in mortality between anemic and normocythemic
patients. In fact, in patients without apparent clinical disease, there is
a trend toward a decreased risk of death in anemic patients. Can the authors
explain this? In addition, was the difference in the mortality rate between
anemic and normocythemic patients statistically significant?